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of locally advanced non-small-cell lung cancers
Nuzhat Jan1, Geoffrey D. Hugo1, Nitai Mukhopadhyay2 and Elisabeth Weiss1*

Abstract
Background and purpose: The need for target adjustment due to respiratory motion variation and the value of
carina as a motion surrogate is evaluated for locally advanced non-small-cell lung cancer.
Material and methods: Using weekly 4D CTs (with audio-visual biofeedback) of 12 patients, respiratory motion
variation of primary tumors (PT), lymph nodes (LN) and carina (C) were determined.
Results: Mean (SD) 3D respiratory motion ranges of PT, LN and C were 4 (3), 5 (3) and 5 (3) mm. PT and LN (p = 0.003),
and LN and C motion range were correlated (p = 0.03). Only 20 %/5 % of all scans had variations >3 mm/5 mm. Large
respiratory motion range on the initial scan was associated with larger during-treatment variations for PT (p = 0.03) and
LN (p = 0.001).
Mean (SD) 3D relative displacements of PT-C, LN-C and PT-LN were each 6 (2) mm. Variations of displacements >3 mm/
5 mm were observed in 28 %/6 % of scans for PT-LN, 20 %/9 % for PT-C, and 20 %/8 % for LN-C.
Conclusions: Motion reassessment is recommended in patients with large initial motion range. Relative motion-related
displacements between PT and LN were larger than PT and LN motion alone. Both PT and C appear to be comparable
surrogates for LN respiratory motion.
Keywords: Non-small-cell lung cancer, Respiratory motion, Primary tumor, Lymph nodes

Background
The respiratory motion of primary lung tumors (PT) and
involved lymph nodes (LN) has been studied extensively
showing motion ranges up to 3.5 cm for PT [1–6] and
1.5 cm for LN [7–13]. Respiratory motion of locally
advanced non-small-cell lung cancer (LA-NSCLC) is commonly assessed prior to therapy, assuming stable respiratory conditions throughout the course of treatment. Several
longitudinal investigations of PT motion [3, 14–18] reported both stable motion as well as in- or decrease. These
analyses extended over varying time spans and were usually
limited to 2 or 3 repeat scans during treatment. Temporal
variations of mediastinal LN motion have rarely been investigated [13, 19] and covered only short time periods, except
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for one study using implanted markers as surrogates for
mediastinal LN and daily 4D CBCT imaging [11].
Target volumes for LA-NSCLC need to ensure coverage of both PT and involved LN over the whole radiotherapy course. The primary goal of this longitudinal
study is therefore to investigate PT and LN respiratory
motion variation together over the period of a conventional radiation treatment. Investigations so far have focused on either PT or LN and did not analyze the
geometric relationship during respiration between both
parts of the complex target in LA-NSCLC. Knowledge
of PT, LN and PT relative to LN (PT-LN) motion is also
relevant for gated therapies to select appropriate phases
with ideally little respiratory displacement. In addition,
information on PT, LN and PT-LN motion variation is a
prerequisite for the development of target tracking in
LA-NSCLC which is at present only used for early stage
lung cancer without LN involvement. This study also investigates carina (C) as a surrogate for LN respiratory
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motion, as LNs are often not readily visible on onboard
imaging.

Materials and methods
Patients and imaging

Twelve consecutively enrolled patients with stage IIIA
locally advanced non-small-cell lung cancer underwent
weekly 4D CT imaging (4–8 weekly scans per patient)
on a prospective IRB-approved imaging protocol
(Virginia Commonwealth University IRB). Primary tumors were located in the middle and lower lobes in 7
patients, analyzed LNs were in region 4 in 8, and regions
1, 2 and 7 in the remainder of patients [20]. The average
volumes on the planning scan were 77 cm3 (range 7–
392 cm3) for PT and 5 cm3 (range 1–15 cm3) for LN.
The treatment was concurrent radiochemotherapy to a
total dose of 64.8-70 Gy using daily 1.8 or 2 Gy fractions.
A total of 65 4D CTs, each divided into 10 phase bins
using phase-based sorting (Brilliance Big Bore, Philips
Medical Systems, Andover, MA), were acquired with a
slice thickness of 3 mm, 512 × 512 axial resolution and a
50–60 cm field of view. Audiovisual biofeedback was
used throughout imaging and treatment [21, 22].
Contouring

Primary tumor (PT), involved lymph nodes (LN) and
carina (C) were manually contoured by one physician on
the 10 respiratory phases (0, 10, 20 ….., 90 % with 0 %
being end- inspiration and 50-70 % being end-expiration
phase) of each 4D CT using a commercial treatment
planning system (Pinnacle 8.1, Phillips, Fitchburg, WI).
No contrast was used for these scans. All LN and the
parts of PT neighboring mediastinum, diaphragm and
chest wall were contoured in the default mediastinal
window, primary tumors surrounded by lung tissue were
delineated in the lung window. The largest lymph node
in each patient was used for data analysis. Large emphasis was given to high quality contouring given the expected small inter-phase positional variations. Manual
contouring was aided through copying and editing contours between phases and through the use of individualized contouring templates to reduce contour variability
between phases and weekly scans. Peer review was performed for all contours.
Data analysis
Absolute respiratory motion range and relative respirationrelated displacements

The center of mass (centroid) positions of PTs, LNs and
Cs were recorded for all phases on all scans (total of 650
3D CT scans). The range of respiratory motion of all
three structures was determined by calculating the largest differences of the centroid positions on the 10 phase
bins of each 4D CT for the three cardinal directions, x
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(lateral), y (anteroposterior) and z (superior-inferior)
relative to the centroid position in phase 0 %. The largest three dimensional (3D) displacement vector magnitude was determined from the square root of the sum of
the squared x-, y- and z-displacements for each phase
bin per 4D CT. From the maximum ranges of motion
on repeated 4D CTs, the individual patient means, and
from averaging the patient means over all patients, the
population means were determined. The largest displacements in the three cardinal directions might occur
in different breathing phases. The resulting 3D vector
based on these maximum displacements would be
physiologically unrealistic, as there actually is no breathing phase that showed such a high 3D displacement.
Therefore, after calculation of the 3D displacement vector for each phase bin of each scan, the largest 3D vector
per scan was selected from the 10 phase bins and was
typically smaller than expected from the maximum displacements in the individual directions. The patient
means of the 3D displacement vectors were determined
by selecting the largest 3D vector per scan and averaging
over all scans per patient. Phase bins with the largest 3D
vector varied between scans. Patient means were averaged to obtain the population means of 3D displacement
vectors.
Using the centroid coordinates of each structure, relative respiration-related displacements of PT-LN, PT-C,
and LN-C were calculated for each phase of all 4D CTs
for all three cardinal directions by subtracting the x-, yand z-positions of the two respective centroids for each
phase and determining the largest difference per scan.
Mean patient-specific relative displacements were averaged over all patients to obtain the population means for
all directions and 3D vectors. Similar to absolute displacements, the 3D vectors of relative displacements
were selected from the phase bin with the largest 3D
displacement vector per scan.
Time trends in respiratory motion range

Longitudinal variations in respiratory motion ranges
during a course of radiotherapy were calculated as differences in the average ranges of motion between the initial
planning scan (week 1) and subsequent scans. To determine the spectrum of variability within the population,
scans with >1/3/5 mm variation in the respiratory range
and relative displacements of PT, LN and C compared to
the planning scan were identified.
Statistics

Longitudinal data were modeled using a linear mixed effect model, thereby allowing for a random effect of individual patient data on the population model. Fixed
effects in the model were absolute and relative motion
per week and week 1 displacement. Correlation among
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Absolute and relative respiratory motion range

For average range of motion for PT, LN and C see
Table 1. While the range of PT motion was not significantly associated with C motion (p = 0.08), it was significantly associated with LN motion (p = 0.003). Also, LN
and C motion were positively correlated (p = 0.03). Individual 3D patient means of respiratory motion range (all
scans over the treatment course per patient) for PT, LN
and C ranged from 0 to 7, 1 to 9, and 1 to 11 mm,
respectively, indicating large interpatient variations in respiratory motion.
For average range of relative respiration-related displacements of PT-LN, PT-C and LN-C see Table 1. Individual 3D patient means for these relative position
changes ranged from 2 to 10, 2 to 12, and 4 to 10 mm,
respectively.

Average range of motion (mm)

Results

a) Primary Tumor
10.0
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0

x
y
z
3D

week 1 week 2 week 3 week 4 week 5

b) Lymph node
Average range of motion (mm)

repeated measures of the same patients was modeled
using a compound symmetric covariance matrix based on
optimal Akaike information criteria (AIC) and successful
convergence of the optimization process [23]. All analyses
were done using PROC MIXED in SAS v9.3. Results were
assumed to be statistically significant for p < 0.05 for twosided tests. Power calculations were performed for all analyses and showed at least 80 % power for all significant
results.

10.0
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0

x
y
z
3D

week 1 week 2 week 3 week 4 week 5

Time trends in respiratory motion range

Table 1 Average range of respiratory motion for all scans and
patients
Average respiratory motion (± standard deviation) in mm
x

y

z

3D

PT

2 (1)

2 (2)

4 (3)

4 (3)

LN

2 (2)

2 (2)

4 (3)

5 (3)

C

2 (2)

2 (2)

4 (3)

5 (3)

PT-LN

3 (3)

3 (2)

3 (3)

6 (2)

PT-C

2 (2)

3 (2)

5 (3)

6 (2)

LN-C

3 (3)

3 (2)

4 (2)

6 (2)

C: Carina; LN: Lymph nodes; PT: Primary tumor

c) Carina
Average range of motion (mm)

While the mean difference between week 1 and week 5
range of respiratory motion was less than 1 mm for PT,
LN and C for all directions, large interpatient variability
was observed (Fig. 1). 3D variations >1 mm were observed in all but one patient. A change of motion amplitude >3 mm relative to the planning scan was identified
in 11 % of scans for PT and 20 % for LN and C, of which
3, 5 and 9 % were increases. Variations >5 mm were rare
with 5 % for PT and LN, and 11 % for C, of which up to
5 % were increases (Table 2). Larger respiratory motion
range on the initial scan was associated with more variation in subsequent weeks for PT (p = 0.03), LN (p =

10.0
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0

x
y
z
3D

week 1 week 2 week 3 week 4 week 5
Fig. 1 Variation of the range of motion during radiotherapy. Means
and standard deviations of the study population in the three
cardinal directions and as 3D vectors per week for a Primary Tumor,
b Lymph Node and c Carina

0.001), but not C (p = 0.3) (Fig. 2). Two of four patients
with ≥6 mm PT motion, and 3 of 4 patients with ≥8 mm
LN motion amplitude on the initial scan had >5 mm
variations of respiratory amplitude compared to none
below these motion ranges. As shown in Fig. 3, no clear
time trends towards enlarging or diminishing motion
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Table 2 Variability of respiratory motion during the
radiotherapy course for all patients (total 12) and scans
(total 65)

a)

y

z

3D

Patients Scans Patients Scans Patients Scans Patients Scans
PT

1/1

1/1

1/1

1/1

3/1

5/1

4/2

7/2

LN

1/0

1/0

1/1

1/1

6/2

9/4

6/2

13/3

C

3/2

8/5

4/1

8/1

4/2

6/2

7/3

13/6

PTLN

3/3

3/3

4/4

4/4

8/2

15/2

9/8

18/
10

PTC

3/3

7/4

3/2

7/3

7/4

13/5

7/3

13/4

LNC

Change in respiratory motion in cm

> 3 mm change/increase in respiratory motion range and relative
displacement
x

Primary tumor

1.00
0.80
0.60
0.40
0.20
0.00
-0.20
-0.40
-0.60
-0.80
-1.00
1

4/3

11/7

3/2

3/2

5/3

6/4

7/5

13/9

b)

2

3

4

5

4

5

Week

Lymph nodes

>5 mm change/increase in respiratory motion range and relative
displacement
x

y

z

3D

Patients Scans Patients Scans Patients Scans Patients Scans
PT

1/1

1/1

0/0

0/0

1/1

2/2

2/1

3/1

LN

0/0

0/0

1/1

1/1

2/0

3/0

3/0

3/0

C

0/0

0/0

1/1

1/1

1/1

3/2

2/1

7/3

PTLN

3/3

3/3

2/2

2/2

3/1

4/1

3/3

4/3

PTC

1/1

LNC

1/1

1/1

1/1

3/1

5/1

3/1

6/1

Change in respiratory motion in cm

1.00
0.80
0.60
0.40
0.20
0.00
-0.20
-0.40
-0.60
-0.80
-1.00
1

3/2

5/3

1/1

2/2

3/2

C: Carina; LN: Lymph nodes; PT: Primary tumor

3/2

3/2

5/2

2

3
Week

Fig. 3 Variation of respiration-related 3D displacements relative to week
1 (planning scan). Black lines represent patients with either ≥6 mm
primary tumor motion range in a or ≥8 mm lymph node motion range
in b in week 1. Patients with larger motion range on the initial week1
scan were more likely to have a > 5 mm change in motion range.
Changes in respiratory motion in weeks 2–5 are normalized to the week
1motion range

Fig. 2 Relation between week 1 range of motion and longitudinal variability. Larger range of motion of primary tumor (p = 0.03) and lymph node
(p = 0.001) on the week 1 scan is associated with more motion variability on subsequent scans. For each patient, the initial range of motion
(x-axis) versus the standard deviation of the motion range on subsequent scans (y-axis) is shown
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ranges were observed for PT, whereas LN motion ranges
appeared to decrease. These observations need to be
confirmed in larger patient cohorts.
The mean difference between week 1 and week 5 relative
motion-related displacements was ≤ 1 mm, except for PT-C
where the relative motion was smaller by 1.5 mm in week 5
(Fig. 4). Over the course of therapy, variations in the relative
motion-related displacements >3 mm relative to the planning CT were identified in 28 % of scans for PT-LN, 20 %
for PT-C, and 20 % for LN-C. Variations >5 mm were seen
in 6 % for PT-LN, 9 % for PT-C, and 8 % for LN-C

Average relative range of motion (mm)

a)

Primary Tumor - Lymph Node

Average motion range

x
y
z
3D

week 1

Averager elative range of motion (mm)

week 2

week 3

week 4

week 5

Primary Tumor - Carina

10.0
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0
-1.0
-2.0
-3.0

x
y
z
3D

week 1

c)
Average relative range of motion (mm)

Discussion

10.0
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0
-1.0
-2.0
-3.0

b)

(Table 2). Larger relative displacement on the initial scan
was associated with more variation in subsequent weeks,
but was not statistically significant. For PT-LN, the 3 patients with the largest displacements on the initial scans
had >3 mm displacements in 70 % of the subsequent scans.
For PT-C, of 3 patients with >5 mm variations on subsequent scans, 2 patients had >10 mm displacement on the
initial scan. Figure 5 displays occupancy maps of PT-LN
displacement of all scans per patient. Most patients show
variable amounts of displacement over time indicating a
potential benefit of reassessment of respiratory motion
behavior.

week 2

week 3

week 4

week 5

This study provides new information on correlated PT
and associated LN respiratory motion during radiotherapy. The magnitude of motion averaged over the treatment course was comparable for PT and LN with large
interpatient variations. As observed in other reports, the
major trajectory of motion was in craniocaudal direction
both for PT and LN [4, 7, 9, 12, 13, 15, 17, 19]. The
amount of respiratory motion with on average 4 mm in
z-direction for PT and LN in our study appeared smaller
than in other reports with average motion ranges up to
11 mm for PT and up to 7 mm for LN [8, 9, 12]. Larger
PT motion ranges have been reported for small peripheral tumors [4, 5] and lower lobe tumors [3, 15, 24],
whereas in our population of stage IIIA lung cancers no
extreme motion ranges were observed, likely due to adherence or invasion of the mediastinum. It is well known
that the range of LN motion depends on the LN location
[9, 13]. In the present analysis, LN location was, with
one exception, supracarinal. The observed 3D motion of
5 mm agrees well with reports of about 5 mm motion
for region 4 LNs [9, 11, 19]. The average motion for carina was the same as for LN and comparable to 5 mm reported by van der Weide [18].

Lymph node - Carina

10.0
9.0
8.0
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0
-1.0
-2.0
-3.0

Relative respiration-related displacements

x
y
z
3D

week 1

week 2

week 3

week 4

week 5

Fig. 4 Variation of the relative respiration-related displacements. Means
and standard deviations of the study population in the three cardinal
directions and as 3D vectors per week for a Primary Tumor - Lymph
Node, b Primary Tumor - Carina, c Lymph Node - Carina

Relative respiration-related displacement has so far not
been investigated except for a report by Piet et al. [10]
who identified relative motion between C and LN as a
potential cause for low yield rates with transbronchial
biopsy. The displacement between LN-C of 5 mm in zdirection was similar to the 4 mm observed in our study.
Investigation of relative motion is of particular interest
for the development of tumor tracking techniques for
LA-NSCLC [25, 26]. Tracking of LA-NSCLC is challenging as it requires simultaneous tracking of both PT and
LN, with LN usually difficult to identify on planar x-ray
or CBCT images. While LN motion was positively correlated with C motion indicating that C might be a good
surrogate for LN respiratory motion, as C is readily
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Fig. 5 Occupancy maps of relative respiratory motion-related displacements between primary tumors and lymph nodes for individual patients.
Relative 3D displacements between primary tumor and lymph node relative to respiration phase 0–90 (0: end inspiration, 50: end expiration) are
shown for all scans (4–8) per patient. Values were interpolated between neighboring phases. Darker color means that the respective magnitude
of displacement is observed more frequently during respiration. While there is only little displacement with phase, e.g., in patients 3 and 12, other
patients show larger variations of displacement during respirations which are stable on repeat scans, e.g., patients 7 and 8. Most patients show
variable amounts of displacement between scans

visible on standard set up imaging, such as kV x-rays
and CBCT, relative respiration-related displacements
between LN and C were comparable to LN and PT.
Therefore, PT and C appear to be comparable surrogates for respiratory motion of LN. Investigating the

motion properties of PT, LN and surrogates relative to
each other is of interest for the development of motion
models in the complex geometries of lung cancer. In
addition, information on relative respiration-related
displacements is clinically relevant for the selection of
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appropriate breathing phases for gating techniques
where typically end expiration phases with little motion
are selected.
Temporal variations in motion range

High rates of ITV misses during radiotherapy have been
described by Mohammed [27] due to position, motion,
shape and volume changes. The present study focuses
on motion variations, showing that all but one patient
had change in motion range >1 mm. Increased ranges of
motion >3 mm relative to the planning scan, however,
were rare despite the observed volume changes during
treatment. The observed variations of relative displacements were also small. PTV margins of 5 mm covered
98 % of PT, 95 % of C and 100 % of LN and 95 % of PTLN, 98 % of PT-C and 97 % of LN-C relative motion variations assuming use of an ITV to cover initial motion
ranges and free breathing situations. In situations with
larger motion range on the planning scan, margins
might need to be adjusted to cover variations of respiratory motion during therapy. Variations of absolute and
relative motion >5 mm were significantly more frequent
in patients with larger initial motion range suggesting
that patients with large initial motion range might benefit more from reevaluation. So far, few studies have performed repeated motion analysis of PTs over the
treatment course. Britton et al. [15] found increased PT
mobility on weekly 4D CTs and suggested repeated 4D
CT for reassessment of ITVs. Michalski et al. [3] repeated 4D CTs after an average of 34 days and observed
reproducible target motion in 87 %. Redmond et al. [17]
analyzed PT motion on 2 repeat 4D CTs at 30 and
50 Gy and found no significant motion variation. Clearly,
differences in the time periods of reassessment, use or
avoidance of biofeedback strategies and the overall observation period have resulted in these seemingly contradictory findings.
Time trends in lymph node motion have rarely been analyzed. While Thomas et al. [13] evaluated whole LN
regions, Bosmans et al. [19] analyzed individual LN motion over the first 2 weeks of treatment and found only
minor decrease in average motion from 5.6 mm to
5.3 mm. Using implanted markers and daily imaging,
Schaake et al. [11] also found minimal average motion
changes of <1 mm which is in agreement with our findings. While population-based analyses might reveal small
variations, for consideration of re-planning and adaptation, individual patient variations are important. As demonstrated in this study, patients with large initial motion
have also larger variations during treatment and therefore
might benefit from reassessment of their ITVs. Given the
week-to-week variations in motion range, no optimum
time point for reassessment can be defined. The need for
reassessment is influenced by the scenario selected for
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differential (PT and LN or C) motion management in LANSCLC, which depends on the combination of image
guidance strategy (e.g., repeated x-ray imaging, 4D
CBCT), respiration management (e.g., tracking, breath
hold, free breathing) and patient-specific factors (e.g., location and number of involved lymph nodes, availability of
implanted markers in PT and/or LN).
Assuming a scenario of “real-time” PT tracking for LANSCLC during free breathing, day-to-day and intrafraction variations of the respiratory motion range would be
accounted for during the tracking process. Only a small
margin would be required to cover the time lag between
the assessment of the target position and adjustments of
the treatment field. To cover the LN motion in this scenario, an ITV based on appropriate volumetric scans, e.g.,
all breathing phases of a 4D CT planning scan, should be
generated. Based on our findings, both increases in LN
motion range and relative displacements of LN relative to
PT or C > 3 mm are rare and are usually covered by a
5 mm PTV margin with image guidance of either PT or
C. As an alternative to tracking the PT, tracking C or even
LN (provided they are made visible by implanted markers)
would be an option if large ITVs in the mediastinum due
to large LN motion are prohibitive with regards to normal
tissue toxicity. Ideally, all involved targets, PT and LNs,
should be tracked independently for optimum target
coverage and normal tissue sparing. In scenarios without
tracking that use (4D) CBCTs for motion assessment,
ITVs of PT and LNs on the initial scan cover both absolute and relative motion ranges. As shown in our study,
absolute and relative motion increases >5 mm were observed for PT in one scan (2 % of all scans) and for PT-LN
in 3 scans (5 % of all scans). As absolute motion and relative displacement are related, margins of 5 mm should be
sufficient to cover both absolute and relative variations in
respiratory motion. This is, however, an estimate which
ignores other important sources of uncertainty such as delineation error and the quadratic nature of error summation for margin generation.
In the present study, motion range was measured on
4D CTs that cover only few respiratory cycles, potentially underestimating actual intrafraction motion variations. It has been shown, however, that motion ranges in
general remain stable during one fraction [14, 16]. Both
4D CT imaging artifacts and contouring variability
might have influenced the present data. Several measures as described above were applied to improve image
quality and contouring consistency. Most importantly,
only one physician performed all contouring to avoid interobserver variation.

Conclusions
Despite relevant volume shrinkage, the majority of respiratory motion variations were small. Reassessment of
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respiratory motion is, however, recommended in
patients with large initial motion range. Relative
respiration-related displacements were on average larger
than PT and LN respiratory motion alone. C and PT appeared to be comparable surrogates for determining LN
position. Information on relative displacements is relevant for gated treatments and for the development of
tracking in LA-NSCLC and should be investigated
further.
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